StoneX Group
BDRX icon

StoneX Group’s Biodexa Pharmaceuticals BDRX Stock Holding History

StoneX Group’s Portfolio BDRX Stock Details BDRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$8.37K Buy
+1,562
New +$17.8K ﹤0.01% 1865
2021
Q3 		– Hold
0
– -$68K – 474
2021
Q2 		– Hold
0
– – – 466
2021
Q1 		– Hold
0
– – – 407

Other funds holding BDRX

SBI Securities
SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return
Caitong International Asset Management
Caitong International Asset Management Hong Kong $1.04B AUM 150.25% 1-Year Est. Return

StoneX Group's BDRX Position: Q3 2026 in Review

StoneX Group opened a new position in Biodexa Pharmaceuticals (BDRX) in Q3 2026: 1,562 shares worth $8.37K. The stake represents ﹤0.01% of the portfolio and ranks #1865 among its holdings.

2 funds tracked by Wall St. Rank hold BDRX as of Q3 2026.

  • StoneX Group held 1,562 shares of Biodexa Pharmaceuticals worth $8.37K as of Q3 2026.
  • Biodexa Pharmaceuticals was a new StoneX Group position in Q3 2026.
  • Biodexa Pharmaceuticals made up ﹤0.01% of StoneX Group's portfolio in Q3 2026, its #1865 holding.
  • 2 funds tracked by Wall St. Rank held Biodexa Pharmaceuticals as of Q3 2026.

Based on StoneX Group's 13F filing for Q3 2026, filed 3 Nov 2026.